Cervical cancer Cancer Malignant neoplasms of female genital organs
Conditions
Interventions
This will be a randomised controlled pilot study at ~12 GP practices in London within the Hounslow Clinical Commissioning Group (CCG). Each GP practice will recruit over a period of 12 months and will
Sponsors
Queen Mary University of London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Women aged 25-64 years 2. Eligible for cervical screening 3. At least 6 months overdue (i.e. no cervical screening recorded in the GP records in the past 3.5 years if aged 25-49 or 5.5 years if aged 50-64)
Exclusion criteria
Exclusion criteria: Women unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This is a pilot study therefore there is no formal primary outcome measure. The study will calculate measures of feasibility and acceptability such as the proportion of eligible women who are offered kits, accept and return a self-sample following each intervention (i.e. (i) opportunistic offer of self-sampling kits, (ii) women invited to order a self-sampling kit, and (iii) women sent self sampling kit) at 6 months and 12 months after the invitation/offer of self sampling | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The proportion of eligible women who test HPV positive and a) attend for follow up (cytology or colposcopy) within 6 months of testing HPV positive on a SS and b) who are treated for CIN2+ 2. “Coverage” of cervical screening following different interventions – when additionally counting an HPV negative test on self-sample as “screened” 3. Use of website in the intervention arm (women invited to order a kit) | — |
Countries
England, United Kingdom
Outcome results
None listed